Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.01621
Full Text
Open PDFAbstract
Available in full text
Date
July 16, 2018
Authors
Publisher
Frontiers Media SA